MedPath

Effect of resveratrolon vascular functio

Phase 2
Conditions
Type 2 diabetes mellitus.
Type 2 diabetes mellitus
Registration Number
IRCT20171118037528N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
72
Inclusion Criteria

Male and female subjects with established T2DM, who have been diagnosed for at least three months
who have body mass index between 24-30 kgm2,
and aged 30-60 years,

Exclusion Criteria

clinical diagnosis of any liver, kidney, cancer and Alzheimer's diseases
insulin therapy;
HbA1c= 8%
consumption of any antioxidant supplements in the last six months
history of allergic reaction to grapes;
consumption of anticoagulants, fibrates and aspirin
drinking red wine and alcohol
history of myocardial infraction
presence of stent or battery in the heart
gastrointestinal ulcer
pregnancy or lactation;
follow the unusual diet until one month before the study;
unwillingness to participation in study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath